Fisher & Paykel Healthcare Corporation Limited(AU:FPH)
A$39.29-0.15 (-0.38%)
AU:FPH
Fisher & Paykel Healthcare Corporation Limited stock forecast
A$39.29
At close:-0.15 (-0.38%)
Fisher & Paykel Healthcare Corporation Limited (FPH) Share Forecast & Price Target
21 Followers
FPH Analyst Ratings
Strong Buy
6Buy2Hold0Sell
Based on 8 analysts giving stock ratings to Fisher & Paykel Healthcare Corporation Limited in the past 3 months
FPH Stock 12 Month Forecast
Average Price Target
AU$42.96▲(9.33% Upside)Based on 8 Wall Street analysts offering 12 month price targets for Fisher & Paykel Healthcare Corporation Limited in the last 3 months. The average price target is AUD 42.96 with a high forecast of AUD 45.75 and a low forecast of AUD 41.61. The average price target represents a 9.33% change from the last price of AUD 39.29.
Past 12 Months12 Month ForecastJan2026Oct2026
HighAU$45.75
AverageAU$42.96
LowAU$41.61
Highest Price TargetHighestAU$45.75Average Price TargetAU$42.96Lowest Price TargetLowestAU$41.61
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Marcus Curley | UBS | AU$34.26→AU$41.61 | hold | 5.89%Upside | Reiterated | 11/04/26 | ||
| Vanessa Thomson | Jefferies | AU$42.50→AU$45.75 | buy | 16.44%Upside | Reiterated | 10/29/26 | ||
| Craig Wong-Pan | RBC Capital | AU$31.82→AU$42.42 | buy | 7.97%Upside | Upgraded | 09/15/26 | ||
| Laura Sutcliffe | Citi | AU$32.63→AU$41.61 | buy | 5.89%Upside | Upgraded | 09/10/26 | ||
| David Bailey | Morgan Stanley | ― | buy | ― | Reiterated | 08/24/26 | ||
| Adrian Allbon | Jarden | ― | hold | ― | Reiterated | 08/24/26 | ||
| Chris Cooper | J.P. Morgan | AU$43.40 | buy | 10.46%Upside | Reiterated | 08/24/26 | ||
 Unknown AnalystNot Ranked | Macquarie | ― | buy | ― | Reiterated | 08/23/26 | ||
| Shane Storey | Canaccord Genuity | AU$36.50 | buy | -7.10%Downside | Reiterated | 05/27/26 | ||
| Davinthra Thillainathan | Goldman Sachs | AU$42.80→AU$44.10 | buy | 12.24%Upside | Reiterated | 02/23/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Marcus CurleyUBS | HoldReiteratedAU$34.26→AU$41.61 | 11/04/26 | 5.89%Upside | ||
| Vanessa ThomsonJefferies | BuyReiteratedAU$42.50→AU$45.75 | 10/29/26 | 16.44%Upside | ||
| Craig Wong-PanRBC Capital | BuyUpgradedAU$31.82→AU$42.42 | 09/15/26 | 7.97%Upside | ||
| Laura SutcliffeCiti | BuyUpgradedAU$32.63→AU$41.61 | 09/10/26 | 5.89%Upside | ||
| David BaileyMorgan Stanley | BuyReiterated | 08/24/26 | ― | ||
| Adrian AllbonJarden | HoldReiterated | 08/24/26 | ― | ||
| Chris CooperJ.P. Morgan | BuyReiteratedAU$43.40 | 08/24/26 | 10.46%Upside | ||
| Unknown AnalystMacquarieNot Ranked | BuyReiterated | 08/23/26 | ― | ||
| Shane StoreyCanaccord Genuity | BuyReiteratedAU$36.50 | 05/27/26 | -7.10%Downside | ||
| Davinthra ThillainathanGoldman Sachs | BuyReiteratedAU$42.80→AU$44.10 | 02/23/26 | 12.24%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Fisher & Paykel Healthcare Corporation Limited
3 Months
Success Rate6/6 ratings generated profit
100%
Average Return
+16.92%
Copying Chris Cooper's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +16.92% per trade.
1 Year
Success Rate4/4 ratings generated profit
100%
Average Return
+23.88%
Copying Christine Trinh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.88% per trade.
2 Years
Success Rate5/5 ratings generated profit
100%
Average Return
+33.98%
Copying Davinthra Thillainathan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +33.98% per trade.
FPH Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 9 | 5 | 8 | 8 | 4 |
| Hold | 7 | 6 | 6 | 4 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 11 | 14 | 12 | 5 |
In the current month, FPH has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. FPH average Analyst price target in the past 3 months is 42.96.
FPH Financial Forecast
HighAU$0.39
ConsensusAU$0.37
LowAU$0.34
FPH Earnings Forecast
Next quarter’s earnings estimate for FPH is AUD 0.37 with a range of AUD 0.34 to AUD 0.39. The previous quarter’s EPS was AUD 0.35. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighAU$1.03B
ConsensusAU$1.01B
LowAU$977M
FPH Sales Forecast
Next quarter’s sales forecast for FPH is AUD 1.01B with a range of AUD 977.32M to AUD 1.03B. The previous quarter’s sales results were AUD 1.01B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
FPH Stock Forecast FAQ
What is AU:FPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Fisher & Paykel Healthcare Corporation Limited’s 12-month average price target is AU$42.96.
What is AU:FPH’s upside potential, based on the analysts’ average price target?
Fisher & Paykel Healthcare Corporation Limited has 9.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fisher & Paykel Healthcare Corporation Limited a Buy, Sell or Hold?
Fisher & Paykel Healthcare Corporation Limited has a consensus rating of Strong Buy, which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is Fisher & Paykel Healthcare Corporation Limited’s share price target?
The average share price target for Fisher & Paykel Healthcare Corporation Limited is AU$42.96. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is AU$45.75, and the lowest forecast is AU$41.61. The average share price target represents a 9.33% increase from the current price of AU$39.29.
What do analysts say about Fisher & Paykel Healthcare Corporation Limited?
Fisher & Paykel Healthcare Corporation Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Fisher & Paykel Healthcare Corporation Limited?
To buy shares of AU:FPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
